HENNEY CHRISTOPHER S
Insider CIK 1242880 · CYCC Director · ANTH Director · ONTY Interim CEO and President, Director · PRTA Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CYCC Cyclacel Pharmaceuticals, | A Award deriv | 2023-06-30 | 2023-07-03 | 42,438 | — | $0 | 42,438 | SEC↗ |
| CYCC Cyclacel Pharmaceuticals, | A Award | 2023-06-30 | 2023-07-03 | 21,219 | — | $0 | 39,415 | SEC↗ |
| CYCC Cyclacel Pharmaceuticals, | A Award deriv | 2022-06-14 | 2022-06-16 | 31,645 | — | $0 | 31,645 | SEC↗ |
| CYCC Cyclacel Pharmaceuticals, | A Award | 2022-06-14 | 2022-06-16 | 15,822 | — | $0 | 18,196 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | M Exercise deriv | 2021-07-14 | 2021-07-16 | 11,108 | — | $0 | 0 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | S Sale | 2021-07-14 | 2021-07-16 | 9,108 | $55.31 | $503.8K | 2,000 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | M Exercise | 2021-07-14 | 2021-07-16 | 11,108 | $11.33 | $125.9K | 11,108 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | S Sale | 2021-07-14 | 2021-07-16 | 2,000 | $56.13 | $112.3K | 0 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | M Exercise deriv | 2021-07-12 | 2021-07-12 | 6,392 | — | $0 | 11,108 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | M Exercise deriv | 2021-07-12 | 2021-07-12 | 17,500 | — | $0 | 0 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | M Exercise deriv | 2021-07-12 | 2021-07-13 | 17,500 | — | $0 | 0 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | M Exercise deriv | 2021-07-12 | 2021-07-13 | 6,392 | — | $0 | 11,108 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | S Sale | 2021-07-12 | 2021-07-12 | 2,100 | $56.56 | $118.8K | 1,977 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | S Sale | 2021-07-12 | 2021-07-12 | 2,315 | $55.26 | $127.9K | 4,077 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | M Exercise | 2021-07-12 | 2021-07-12 | 6,392 | $11.33 | $72.4K | 6,392 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | S Sale | 2021-07-12 | 2021-07-12 | 177 | $61.25 | $10.8K | 0 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | S Sale | 2021-07-12 | 2021-07-12 | 600 | $59.25 | $35.5K | 177 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | S Sale | 2021-07-12 | 2021-07-12 | 500 | $58.21 | $29.1K | 777 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | S Sale | 2021-07-12 | 2021-07-12 | 1,634 | $56.88 | $92.9K | 1,277 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | S Sale | 2021-07-12 | 2021-07-12 | 800 | $58.66 | $46.9K | 477 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | S Sale | 2021-07-12 | 2021-07-12 | 300 | $59.45 | $17.8K | 177 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | S Sale | 2021-07-12 | 2021-07-12 | 177 | $61.25 | $10.8K | 0 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | M Exercise | 2021-07-12 | 2021-07-12 | 17,500 | $9.23 | $161.5K | 17,500 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | S Sale | 2021-07-12 | 2021-07-12 | 6,228 | $53.84 | $335.3K | 11,272 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | S Sale | 2021-07-12 | 2021-07-12 | 5,886 | $54.55 | $321.1K | 5,386 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | S Sale | 2021-07-12 | 2021-07-12 | 2,475 | $55.95 | $138.5K | 2,911 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | S Sale | 2021-07-12 | 2021-07-12 | 700 | $57.85 | $40.5K | 1,277 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | S Sale | 2021-07-12 | 2021-07-13 | 6,228 | $53.84 | $335.3K | 11,272 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | S Sale | 2021-07-12 | 2021-07-13 | 300 | $59.45 | $17.8K | 177 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | S Sale | 2021-07-12 | 2021-07-13 | 800 | $58.66 | $46.9K | 477 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | S Sale | 2021-07-12 | 2021-07-13 | 700 | $57.85 | $40.5K | 1,277 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | S Sale | 2021-07-12 | 2021-07-13 | 2,100 | $56.56 | $118.8K | 1,977 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | S Sale | 2021-07-12 | 2021-07-13 | 2,315 | $55.26 | $127.9K | 4,077 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | M Exercise | 2021-07-12 | 2021-07-13 | 6,392 | $11.33 | $72.4K | 6,392 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | S Sale | 2021-07-12 | 2021-07-13 | 177 | $61.25 | $10.8K | 0 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | S Sale | 2021-07-12 | 2021-07-13 | 600 | $59.25 | $35.5K | 177 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | S Sale | 2021-07-12 | 2021-07-13 | 500 | $58.21 | $29.1K | 777 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | S Sale | 2021-07-12 | 2021-07-13 | 1,634 | $56.88 | $92.9K | 1,277 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | S Sale | 2021-07-12 | 2021-07-13 | 2,475 | $55.95 | $138.5K | 2,911 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | S Sale | 2021-07-12 | 2021-07-13 | 5,886 | $54.55 | $321.1K | 5,386 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | S Sale | 2021-07-12 | 2021-07-13 | 177 | $61.25 | $10.8K | 0 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | M Exercise | 2021-07-12 | 2021-07-13 | 17,500 | $9.23 | $161.5K | 17,500 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | M Exercise deriv | 2021-06-25 | 2021-06-29 | 12,000 | — | $0 | 0 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | S Sale | 2021-06-25 | 2021-06-29 | 10,264 | $47.57 | $488.3K | 1,736 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | S Sale | 2021-06-25 | 2021-06-29 | 1,736 | $48.73 | $84.6K | 0 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | M Exercise | 2021-06-25 | 2021-06-29 | 12,000 | $16.43 | $197.2K | 12,000 | SEC↗ |
| CYCC Cyclacel Pharmaceuticals, | A Award deriv | 2021-06-15 | 2021-06-17 | 4,748 | — | $0 | 4,748 | SEC↗ |
| CYCC Cyclacel Pharmaceuticals, | A Award | 2021-06-15 | 2021-06-17 | 2,374 | — | $0 | 2,374 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | A Award deriv | 2021-05-19 | 2021-05-21 | 15,000 | — | $0 | 15,000 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | A Award deriv | 2021-02-12 | 2021-02-17 | 6,315 | — | $0 | 6,315 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | D To issuer deriv | 2021-02-12 | 2021-02-17 | 12,000 | — | $0 | 0 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | A Award deriv | 2021-02-12 | 2021-02-17 | 8,426 | — | $0 | 8,426 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | D To issuer deriv | 2021-02-12 | 2021-02-17 | 15,000 | — | $0 | 0 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | A Award deriv | 2021-02-12 | 2021-02-17 | 9,803 | — | $0 | 9,803 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | D To issuer deriv | 2021-02-12 | 2021-02-17 | 15,000 | — | $0 | 0 | SEC↗ |
| CYCC Cyclacel Pharmaceuticals, | A Award deriv | 2020-06-25 | 2020-06-29 | 5,200 | — | $0 | 5,200 | SEC↗ |
| PRTA Prothena Corp plc | A Award deriv | 2020-05-20 | 2020-05-22 | 17,500 | — | $0 | 17,500 | SEC↗ |
| CYCC Cyclacel Pharmaceuticals, | A Award deriv | 2019-05-29 | 2019-05-31 | 18,750 | — | $0 | 18,750 | SEC↗ |
| PRTA Prothena Corp plc | A Award deriv | 2019-05-22 | 2019-05-24 | 17,500 | — | $0 | 17,500 | SEC↗ |
| CYCC Cyclacel Pharmaceuticals, | A Award deriv | 2018-05-31 | 2018-06-04 | 8,576 | — | $0 | 8,576 | SEC↗ |
| PRTA Prothena Corp plc | A Award deriv | 2018-05-16 | 2018-05-18 | 12,000 | — | $0 | 12,000 | SEC↗ |
| CASC Cascadian Therapeutics, In | D To issuer deriv | 2018-03-09 | 2018-03-13 | 13,927 | — | $0 | 0 | SEC↗ |
| CASC Cascadian Therapeutics, In | D To issuer deriv | 2018-03-09 | 2018-03-13 | 25,000 | — | $0 | 0 | SEC↗ |
| CASC Cascadian Therapeutics, In | U Tender | 2018-03-09 | 2018-03-13 | 60,185 | — | $0 | 0 | SEC↗ |
| ANTH Anthera Pharmaceuticals In | A Award deriv | 2018-01-05 | 2018-01-09 | 84,705 | — | $0 | 84,705 | SEC↗ |
| ANTH Anthera Pharmaceuticals In | A Award deriv | 2018-01-05 | 2018-01-09 | 84,705 | — | $0 | 84,705 | SEC↗ |
| PRTA Prothena Corp plc | M Exercise deriv | 2017-09-28 | 2017-09-29 | 900 | — | $0 | 14,100 | SEC↗ |
| PRTA Prothena Corp plc | S Sale | 2017-09-28 | 2017-09-29 | 900 | $70.00 | $63.0K | 0 | SEC↗ |
| PRTA Prothena Corp plc | M Exercise | 2017-09-28 | 2017-09-29 | 900 | $6.65 | $6.0K | 900 | SEC↗ |
| CASC Cascadian Therapeutics, In | M Exercise deriv | 2017-09-24 | 2017-09-26 | 2,375 | — | $0 | 0 | SEC↗ |
| CASC Cascadian Therapeutics, In | F Tax w/h | 2017-09-24 | 2017-09-26 | 594 | $3.94 | $2.3K | 60,185 | SEC↗ |
| CASC Cascadian Therapeutics, In | M Exercise | 2017-09-24 | 2017-09-26 | 2,375 | — | $0 | 60,779 | SEC↗ |
| PRTA Prothena Corp plc | M Exercise deriv | 2017-07-17 | 2017-07-19 | 5,000 | — | $0 | 15,000 | SEC↗ |
| PRTA Prothena Corp plc | S Sale | 2017-07-17 | 2017-07-19 | 5,000 | $66.13 | $330.6K | 0 | SEC↗ |
| PRTA Prothena Corp plc | M Exercise | 2017-07-17 | 2017-07-19 | 5,000 | $6.65 | $33.3K | 5,000 | SEC↗ |
| CASC Cascadian Therapeutics, In | M Exercise deriv | 2017-06-24 | 2017-06-27 | 9,058 | — | $0 | 0 | SEC↗ |
| CASC Cascadian Therapeutics, In | M Exercise | 2017-06-24 | 2017-06-27 | 9,058 | — | $0 | 60,669 | SEC↗ |
| CASC Cascadian Therapeutics, In | F Tax w/h | 2017-06-24 | 2017-06-27 | 2,265 | $3.78 | $8.6K | 58,404 | SEC↗ |
| CASC Cascadian Therapeutics, In | M Exercise deriv | 2017-06-12 | 2017-06-13 | 2,148 | — | $0 | 0 | SEC↗ |
| CASC Cascadian Therapeutics, In | F Tax w/h | 2017-06-12 | 2017-06-13 | 537 | $3.34 | $1.8K | 51,611 | SEC↗ |
| CASC Cascadian Therapeutics, In | M Exercise | 2017-06-12 | 2017-06-13 | 2,148 | — | $0 | 52,148 | SEC↗ |
| CASC Cascadian Therapeutics, In | A Award deriv | 2017-06-09 | 2017-06-13 | 13,927 | — | $0 | 13,927 | SEC↗ |
| CYCC Cyclacel Pharmaceuticals, | A Award deriv | 2017-05-30 | 2017-06-01 | 2,000 | — | $0 | 2,000 | SEC↗ |
| PRTA Prothena Corp plc | A Award deriv | 2017-05-18 | 2017-05-19 | 12,000 | — | $0 | 12,000 | SEC↗ |
| PRTA Prothena Corp plc | M Exercise deriv | 2017-02-27 | 2017-03-01 | 5,989 | — | $0 | 20,000 | SEC↗ |
| PRTA Prothena Corp plc | M Exercise | 2017-02-27 | 2017-03-01 | 5,989 | $6.65 | $39.8K | 5,989 | SEC↗ |
| PRTA Prothena Corp plc | S Sale | 2017-02-27 | 2017-03-01 | 5,989 | $57.16 | $342.3K | 0 | SEC↗ |
| PRTA Prothena Corp plc | M Exercise deriv | 2017-02-17 | 2017-02-22 | 4,011 | — | $0 | 25,989 | SEC↗ |
| PRTA Prothena Corp plc | S Sale | 2017-02-17 | 2017-02-22 | 4,011 | $57.06 | $228.9K | 0 | SEC↗ |
| PRTA Prothena Corp plc | M Exercise | 2017-02-17 | 2017-02-22 | 4,011 | $6.65 | $26.7K | 4,011 | SEC↗ |
| CASC Cascadian Therapeutics, In | P Buy | 2017-01-30 | 2017-02-01 | 25,324 | $4.11 | $104.1K | 50,000 | SEC↗ |
| ANTH Anthera Pharmaceuticals In | A Award deriv | 2016-12-08 | 2016-12-08 | 83,910 | — | $0 | 83,910 | SEC↗ |
| CASC Cascadian Therapeutics, In | A Award deriv | 2016-06-24 | 2016-06-28 | 54,347 | — | $0 | 54,347 | SEC↗ |
| CYCC Cyclacel Pharmaceuticals, | A Award deriv | 2016-05-26 | 2016-05-31 | 15,000 | — | $0 | 15,000 | SEC↗ |
| PRTA Prothena Corp plc | A Award deriv | 2016-05-20 | 2016-05-24 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ANTH Anthera Pharmaceuticals In | A Award deriv | 2016-04-27 | 2016-04-29 | 62,069 | — | $0 | 62,069 | SEC↗ |
| ONTY Oncothyreon Inc. | A Award deriv | 2016-03-16 | 2016-03-16 | 150,000 | — | $0 | 150,000 | SEC↗ |
| PRTA Prothena Corp plc | M Exercise deriv | 2015-11-27 | 2015-12-01 | 5,000 | — | $0 | 30,000 | SEC↗ |
| PRTA Prothena Corp plc | S Sale | 2015-11-27 | 2015-12-01 | 5,000 | $75.00 | $375.0K | 0 | SEC↗ |
| PRTA Prothena Corp plc | M Exercise | 2015-11-27 | 2015-12-01 | 5,000 | $6.65 | $33.3K | 5,000 | SEC↗ |
| PRTA Prothena Corp plc | M Exercise deriv | 2015-10-29 | 2015-10-30 | 5,000 | — | $0 | 35,000 | SEC↗ |
| PRTA Prothena Corp plc | S Sale | 2015-10-29 | 2015-10-30 | 5,000 | $55.00 | $275.0K | 0 | SEC↗ |
| PRTA Prothena Corp plc | M Exercise | 2015-10-29 | 2015-10-30 | 5,000 | $6.65 | $33.3K | 5,000 | SEC↗ |
| ONTY Oncothyreon Inc. | A Award deriv | 2015-09-24 | 2015-09-28 | 14,245 | — | $0 | 14,245 | SEC↗ |
| PRTA Prothena Corp plc | M Exercise deriv | 2015-08-07 | 2016-08-05 | 10,000 | — | $0 | 40,000 | SEC↗ |
| PRTA Prothena Corp plc | S Sale | 2015-08-07 | 2016-08-05 | 4,560 | $63.25 | $288.4K | 1,040 | SEC↗ |
| PRTA Prothena Corp plc | S Sale | 2015-08-07 | 2016-08-05 | 4,400 | $62.34 | $274.3K | 5,600 | SEC↗ |
| PRTA Prothena Corp plc | S Sale | 2015-08-07 | 2016-08-05 | 1,040 | $64.03 | $66.6K | 0 | SEC↗ |
| PRTA Prothena Corp plc | M Exercise | 2015-08-07 | 2016-08-05 | 10,000 | $6.65 | $66.5K | 10,000 | SEC↗ |
| PRTA Prothena Corp plc | M Exercise deriv | 2015-08-07 | 2015-08-07 | 10,000 | — | $0 | 40,000 | SEC↗ |
| PRTA Prothena Corp plc | M Exercise | 2015-08-07 | 2015-08-07 | 10,000 | $6.41 | $64.1K | 10,000 | SEC↗ |
| PRTA Prothena Corp plc | S Sale | 2015-08-07 | 2015-08-07 | 4,400 | $62.34 | $274.3K | 5,600 | SEC↗ |
| PRTA Prothena Corp plc | S Sale | 2015-08-07 | 2015-08-07 | 1,040 | $64.03 | $66.6K | 0 | SEC↗ |
| PRTA Prothena Corp plc | S Sale | 2015-08-07 | 2015-08-07 | 4,560 | $63.25 | $288.4K | 1,040 | SEC↗ |
| ONTY Oncothyreon Inc. | M Exercise deriv | 2015-06-13 | 2015-06-16 | 16,042 | — | $0 | 0 | SEC↗ |
| PRTA Prothena Corp plc | A Award deriv | 2015-05-22 | 2015-05-26 | 15,000 | — | $0 | 15,000 | SEC↗ |
| CYCC Cyclacel Pharmaceuticals, | A Award deriv | 2015-05-22 | 2015-05-26 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ANTH Anthera Pharmaceuticals In | A Award deriv | 2015-05-21 | 2015-05-22 | 43,269 | — | $0 | 43,269 | SEC↗ |
| ANTH Anthera Pharmaceuticals In | A Award deriv | 2014-12-30 | 2015-01-02 | 16,250 | — | $0 | 16,250 | SEC↗ |
| ONTY Oncothyreon Inc. | M Exercise | 2014-06-13 | 2015-06-16 | 16,042 | — | $0 | 139,818 | SEC↗ |
| ONTY Oncothyreon Inc. | F Tax w/h | 2014-06-13 | 2015-06-16 | 4,011 | $3.88 | $15.6K | 135,807 | SEC↗ |
| ANTH Anthera Pharmaceuticals In | A Award deriv | 2014-06-13 | 2014-06-16 | 15,625 | — | $0 | 15,625 | SEC↗ |
| ONTY Oncothyreon Inc. | A Award deriv | 2014-06-12 | 2015-06-16 | 12,886 | — | $0 | 12,886 | SEC↗ |
| ONTY Oncothyreon Inc. | F Tax w/h | 2014-06-07 | 2014-06-10 | 2,044 | $3.06 | $6.3K | 123,776 | SEC↗ |
| ONTY Oncothyreon Inc. | A Award deriv | 2014-06-06 | 2014-06-10 | 16,339 | — | $0 | 16,339 | SEC↗ |
| CYCC Cyclacel Pharmaceuticals, | A Award deriv | 2014-05-22 | 2014-05-23 | 9,000 | — | $0 | 9,000 | SEC↗ |
| ONTY Oncothyreon Inc. | M Exercise deriv | 2014-03-11 | 2014-03-12 | 19,352 | — | $0 | 0 | SEC↗ |
| ONTY Oncothyreon Inc. | M Exercise | 2014-03-11 | 2014-03-12 | 19,352 | — | $0 | 130,658 | SEC↗ |
| ONTY Oncothyreon Inc. | F Tax w/h | 2014-03-11 | 2014-03-12 | 4,838 | $3.65 | $17.7K | 125,820 | SEC↗ |
| ONTY Oncothyreon Inc. | A Award deriv | 2013-06-13 | 2013-06-14 | 16,042 | — | $0 | 16,042 | SEC↗ |
| ONTY Oncothyreon Inc. | F Tax w/h | 2013-06-09 | 2013-06-11 | 1,135 | $1.86 | $2.1K | 111,306 | SEC↗ |
| CYCC Cyclacel Pharmaceuticals, | A Award deriv | 2013-05-22 | 2013-05-23 | 7,142 | — | $0 | 7,142 | SEC↗ |
| ANTH Anthera Pharmaceuticals In | A Award deriv | 2013-05-17 | 2013-05-20 | 125,000 | — | $0 | 125,000 | SEC↗ |
| PRTA Prothena Corp plc | A Award deriv | 2013-03-18 | 2013-03-19 | 50,000 | — | $0 | 50,000 | SEC↗ |
| ANTH Anthera Pharmaceuticals In | P Buy | 2012-06-29 | 2012-07-02 | 100,000 | $0.75 | $75.0K | 100,000 | SEC↗ |
| ANTH Anthera Pharmaceuticals In | P Buy | 2012-06-29 | 2012-07-02 | 100,000 | $0.75 | $75.0K | 202,429 | SEC↗ |
| ONTY Oncothyreon Inc. | A Award | 2012-06-07 | 2012-06-08 | 8,174 | $3.67 | $30.0K | 112,441 | SEC↗ |
| ONTY Oncothyreon Inc. | F Tax w/h | 2012-06-03 | 2012-06-05 | 2,021 | $3.51 | $7.1K | 104,267 | SEC↗ |
| CYCC Cyclacel Pharmaceuticals, | A Award deriv | 2012-05-23 | 2012-05-24 | 50,000 | — | $0 | 50,000 | SEC↗ |
| ANTH Anthera Pharmaceuticals In | A Award deriv | 2012-05-08 | 2012-05-10 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ONTY Oncothyreon Inc. | M Exercise deriv | 2012-05-03 | 2012-05-04 | 989 | — | $0 | 0 | SEC↗ |
| ONTY Oncothyreon Inc. | F Tax w/h | 2012-05-03 | 2012-05-04 | 247 | $4.15 | $1.0K | 106,288 | SEC↗ |
| ONTY Oncothyreon Inc. | M Exercise | 2012-05-03 | 2012-05-04 | 989 | — | $0 | 106,535 | SEC↗ |
| ONTY Oncothyreon Inc. | M Exercise deriv | 2011-12-31 | 2012-01-03 | 2,388 | — | $0 | 0 | SEC↗ |
| ONTY Oncothyreon Inc. | F Tax w/h | 2011-12-31 | 2012-01-03 | 597 | $7.58 | $4.5K | 105,546 | SEC↗ |
| ONTY Oncothyreon Inc. | M Exercise | 2011-12-31 | 2012-01-03 | 2,388 | — | $0 | 106,143 | SEC↗ |